Dronis P Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Drospirenone (4mg)
Overview Dronis P Tablet
Progesta-C (a hypothetical name) tablets serve as a component within combined oral contraceptive regimens, frequently utilized as birth control. This synthetic progesterone formulation is highly effective in pregnancy prevention when administered as directed. Progesta-C can be ingested with or without food, typically once daily at the same time for maximum efficacy. Adherence to prescribed dosing instructions is crucial, avoiding missed pills. If vomiting or severe diarrhea occurs within hours of intake, a secondary contraceptive method is advised. Commonly reported side effects include headaches, nausea, breast sensitivity, vaginal bleeding irregularities, and menstrual cycle alterations; these are usually mild and transient. Persistent or troublesome effects warrant medical consultation. Progesta-C is not universally appropriate; individuals with clotting disorders, certain cancers, hepatic impairment, or uncontrolled hypertension should abstain. Complete disclosure of all medications, supplements, and pre-existing health issues to your physician is essential prior to commencement. Concurrent smoking significantly elevates the risk of serious cardiovascular complications and should be ceased.
Uses of Dronis P Tablet
Birth control
Major Benefits of Dronis P Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dronis P Tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dronis P Tablet:
- Acne
- Metrorrhagia (menstrual bleeding at irregular intervals)
- Headache
- Nausea
- Breast pain
- Weight gain
- Pain during periods
- Vaginal bleeding
- Decreased libido
- Breast tenderness
- Menstrual disorder
How to use Dronis P Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dronis P Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
How Dronis P Tablet works:
Dronis P Tablet contains progestin, a type of female hormone. Its mechanism of action in preventing pregnancy involves suppressing ovulation (egg release) and hindering fertilization. Additionally, it alters the uterine lining, creating an unfavorable environment for implantation and thus preventing pregnancy establishment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dronis P Tablet may pose safety risks; physician consultation is advised.
PregnancySAFE IF PRESCRIBED
Use of Dronis P Tablet during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Dronis P Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dronis P Tablet.
KidneyUNSAFE
Patients with kidney disease should not take Dronis P Tablet due to potential safety risks. Women with impaired kidney function are specifically advised against its use. Physician consultation is recommended.
LiverUNSAFE
The use of Dronis P Tablet is likely hazardous for individuals with liver conditions and should be avoided. A physician's consultation is recommended. $med_name is not suitable for women experiencing liver dysfunction.
What if you forget to take Dronis P Tablet :
Should you forget a Dronis P Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Dronis P Tablet
| Label | Value |
|---|---|
| Chemical Category | Progesterone Derivatives, Spironolactone Analog |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | Third-generation progestins |





